Stock comparison
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($440.14 B vs $308.78 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($440.14 B vs $308.78 B).
Market value leader
ABBV
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($440.14 B vs $308.78 B).
Revenue leader
MRK
MRK: $65.01B vs ABBV: $61.16B.
Profit leader
MRK
MRK: $18.25B vs ABBV: $4.23B.
Margin leader
MRK
MRK: 28.1% vs ABBV: 6.9% net margin.
| Metric | MRK | ABBV |
|---|---|---|
| Market cap | $308.78 B | $440.14 B |
| US-listed rank | #45 | #25 |
| Revenue (latest FY) | $65.01B | $61.16B |
| Net income (latest FY) | $18.25B | $4.23B |
| Net margin | 28.1% | 6.9% |
| P/E (trailing FY) | 16.9x | 104.2x |
| SEC filings | 998 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($440.14 B vs $308.78 B).
In their latest fiscal years, Merck & Co., Inc. reported $65.01B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Merck & Co., Inc. and AbbVie Inc., or browse the full rankings.